Related references
Note: Only part of the references are listed.The Efficacy and Safety of 200 Days Valganciclovir Cytomegalovirus Prophylaxis in High-Risk Kidney Transplant Recipients
A. Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2010)
Evidence for a Bidirectional Relationship between Cytomegalovirus Replication and acute Graft-versus-Host Disease
Nathan Cantoni et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2010)
Immune monitoring with iTAg MHC Tetramers for prediction of recurrent or persistent cytomegalovirus infection or disease in allogeneic hematopoietic stem cell transplant recipients: a prospective multicenter study
Jan W. Gratama et al.
BLOOD (2010)
Cytomegalovirus disease among donor-positive/recipient-negative lung transplant recipients in the era of valganciclovir prophylaxis
Dimitra Mitsani et al.
JOURNAL OF HEART AND LUNG TRANSPLANTATION (2010)
Ex Vivo Monitoring of Human Cytomegalovirus-Specific CD8+ T-Cell Responses Using the QuantiFERON®-CMV Assay in Allogeneic Hematopoietic Stem Cell Transplant Recipients Attending an Irish Hospital
T. Fleming et al.
JOURNAL OF MEDICAL VIROLOGY (2010)
A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+and CD8+T cells in kidney allograft recipients at risk of CMV infection
Albert J. Eid et al.
TRANSPLANT INTERNATIONAL (2010)
International Consensus Guidelines on the Management of Cytomegalovirus in Solid Organ Transplantation
Camille N. Kotton et al.
TRANSPLANTATION (2010)
Cytomegalovirus in Solid Organ Transplant Recipients
A. Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Clinical Utility of Measuring T-Cell Immunity to CMV in Transplant Recipients
L. Danziger-Isakov et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
Cell-Mediated Immunity to Predict Cytomegalovirus Disease in High-Risk Solid Organ Transplant Recipients
D. Kumar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2009)
How I treat cytomegalovirus in hematopoietic cell transplant recipients
Michael Boeckh et al.
BLOOD (2009)
Immunobiology of Human Cytomegalovirus: from Bench to Bedside
Tania Crough et al.
CLINICAL MICROBIOLOGY REVIEWS (2009)
Functional impairment of cytomegalovirus specific CD8 T cells predicts high-level replication after renal transplantation
F. M. Mattes et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Improvement in long-term renal graft survival due to CMV prophylaxis with oral ganciclovir: Results of a randomized clinical trial
V. Kliem et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
Linking CMV serostatus to episodes of CMV reactivation following lung transplantation by measuring CMV-specific CD8+ T-cell immunity
G. P. Westall et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2008)
CMV infections after hematopoietic stem cell transplantation
P. Ljungman
BONE MARROW TRANSPLANTATION (2008)
Delayed-onset primary cytomegalovirus disease and the risk of allograft failure and mortality after kidney transplantation
Supha K. Arthurs et al.
CLINICAL INFECTIOUS DISEASES (2008)
Cost-effectiveness of a new combined immunosuppressive and anti-infectious regimen in kidney transplantation
Jean-Blaise Wasserfallen et al.
INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE (2008)
Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients
Adrian Egli et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
What Is the Impact of Late-Onset Cytomegalovirus Disease After Valganciclovir Prophylaxis in Kidney Transplantation?
Frederic Lamoth et al.
TRANSPLANTATION (2008)
Symptomatic and asymptomatic viral recrudescence in solid-organ transplant recipients and its relationship with the antigen-specific CD8+ T-cell response
Tanta Crough et al.
JOURNAL OF VIROLOGY (2007)
Human cytomegalovirus (CMV)-specific CD8+ T cell responses are reduced in HIV-infected individuals with a history of CMV disease despite CD4+ T cell recovery
K. P. Singh et al.
CLINICAL IMMUNOLOGY (2007)
Late-onset cytomegalovirus disease in patients with solid organ transplant
Pascal R. Meylan et al.
CURRENT OPINION IN INFECTIOUS DISEASES (2007)
The influence of innate immunity gene receptors polymorphisms in renal transplant infections
Carlos Cervera et al.
TRANSPLANTATION (2007)
Association between mannose-binding lectin deficiency and cytomegalovirus infection after kidney transplantation
Oriol Manuel et al.
TRANSPLANTATION (2007)
Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON (R)-CMV
S. Walker et al.
TRANSPLANT INFECTIOUS DISEASE (2007)
Monitoring of human cytomegalovirus-specific CD4+ and CD8+ T-cell immunity in patients receiving solid organ transplantation
G. Gerna et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis
Ajit P. Limaye et al.
TRANSPLANTATION (2006)
Hypogammaglobulinemia in liver transplant recipients: Incidence, timing, risk factors, and outcomes
S Doron et al.
TRANSPLANTATION (2006)
Cytomegalovirus-specific immunity and protection against viremia and disease in HIV-infected patients in the era of highly active antiretroviral therapy
A Weinberg et al.
JOURNAL OF INFECTIOUS DISEASES (2006)
American society of transplantation recommendations for screening, monitoring and reporting of infectious complications in immunosuppression trials in recipients of organ transplantation
A Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2006)
Cytomegalovirus disease in the era of highly active antiretroviral therapy (HAART)
Christoph Steininger et al.
JOURNAL OF CLINICAL VIROLOGY (2006)
Differences in CMV-specific T-cell levels and long-term susceptibility to CMV infection after kidney, heart and lung transplantation
U Sester et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients
A Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells
T Bunde et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Functional heterogeneity of memory CD4 T cell responses in different conditions of antigen exposure and persistence
A Harari et al.
JOURNAL OF IMMUNOLOGY (2005)
Cellular immune responses to cytomegalovirus in renal transplant recipients
R Radha et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Results of a cytomegalovirus (CMV)-specific CD8+/interferon-γ+ cytokine flow cytometry assay correlate with clinical evidence of protective immunity in patients with AIDS with CMV retinitis
MA Jacobson et al.
JOURNAL OF INFECTIOUS DISEASES (2004)
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients
C Paya et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Clinical utility of cytomegalovirus viral load testing for predicting CMV disease in D+/R- solid organ transplant recipients
A Humar et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
The impact of cytomegalovirus serostatus of donor and recipient before hematopoietic stem cell transplantation in the era of antiviral prophylaxis and preemptive therapy
M Boeckh et al.
BLOOD (2004)
Human cytomegalovirus: clinical aspects, immune regulation, and emerging treatments
MK Gandhi et al.
LANCET INFECTIOUS DISEASES (2004)
Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation:: A collaborative transplant study report
G Opelz et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2004)
Cytomegalovirus-specific IFN-γ production is associated with protection against cytomegalovirus reactivation in HIV-infected patients on highly active antiretroviral therapy
A Weinberg et al.
AIDS (2003)
Cytomegalovirus in hematopoietic stem cell transplant recipients: Current status, known challenges, and future strategies
M Boeckh et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2003)
Sensitive detection of human cytomegalovirus peptide-specific cytotoxic T-lymphocyte responses by interferon-γ-enzyme-linked immunospot assay and flow cytometry in healthy individuals and in patients after allogeneic stem cell transplantation
H Hebart et al.
BLOOD (2002)
Levels of virus-specific CD4 T cells correlate with cytomegalovirus control and predict virus-induced disease after renal transplantation
M Sester et al.
TRANSPLANTATION (2001)
Changes in the natural history of cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy
JR Deayton et al.
AIDS (2000)
Plasma cytomegalovirus DNA, pp65 antigenaemia and a low CD4 cell count remain risk factors for cytomegalovirus disease in patients receiving highly active antiretroviral therapy
D Salmon-Céron et al.
AIDS (2000)
Share Paper
